Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Anika Therapeutics (ANIK) over the last 13 years, with Sep 2025 value amounting to -$219,000.

  • Anika Therapeutics' Other Working Capital Changes fell 198.65% to -$219,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 41.36%. This contributed to the annual value of -$2.1 million for FY2024, which is 3.12% up from last year.
  • Per Anika Therapeutics' latest filing, its Other Working Capital Changes stood at -$219,000 for Q3 2025, which was up 78.10% from -$1.0 million recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Other Working Capital Changes registered a high of $1.2 million during Q1 2022, and its lowest value of -$2.0 million during Q3 2022.
  • For the 3-year period, Anika Therapeutics' Other Working Capital Changes averaged around -$477,000, with its median value being -$219,000 (2025).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 2,012.50% in 2021, then surged by 1,466.67% in 2022.
  • Quarterly analysis of 5 years shows Anika Therapeutics' Other Working Capital Changes stood at $238,000 in 2021, then crashed by 281.09% to -$431,000 in 2022, then plummeted by 208.82% to -$1.3 million in 2023, then dropped by 18.56% to -$1.6 million in 2024, then slumped by 198.65% to -$219,000 in 2025.
  • Its Other Working Capital Changes was -$219,000 in Q3 2025, compared to -$1.0 million in Q2 2025 and $203,000 in Q1 2025.